 Dr Lal Path Labs Ltd reports Rs. 150.6 crores consolidated profit in Q2 FY26
Dr Lal Path Labs Ltd reports Rs. 150.6 crores consolidated profit in Q2 FY26 Sammaan Capital Ltd consolidated Q2 FY2025-26 net profit at Rs. 308.47 crores
Sammaan Capital Ltd consolidated Q2 FY2025-26 net profit at Rs. 308.47 crores Aptus Value Housing Finance India Ltd Q2 FY2026 consolidated PAT higher at Rs. 226.54 crores
Aptus Value Housing Finance India Ltd Q2 FY2026 consolidated PAT higher at Rs. 226.54 crores Sigma Solve Ltd Q2 FY2026 consolidated profit up at Rs. 6.64 crores
Sigma Solve Ltd Q2 FY2026 consolidated profit up at Rs. 6.64 crores Bajaj Electricals Ltd consolidated Q2FY26 PAT at Rs. 9.86 crores
Bajaj Electricals Ltd consolidated Q2FY26 PAT at Rs. 9.86 crores 
              Lyka Labs Ltd has announced that the Committee of Directors (CoD) of the Company at its meeting held on March 30, 2007 have converted 3,75,000 Equity Share Warrants into 3,75,000 Equity Shares at Rs 10/- each at a premium of Rs 31.50/- per share (Exercise Price Rs 41.50/- per warrant) to the persons mentioned as under:
1. Mr. Kunal Gandhi - 1,87,500 - Promoter (No of Warrants allotted) & 1,87,500 (No of shares allotted)
2. N J Gandhi HUF - 1,87,500 - Promoter (No of Warrants allotted) & 1,87,500 (No of shares allotted).